Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues. 2017

Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou 510515, PR China.

Thirty-two novel 3-alkylsulfanyl-1,2,4-triazole derivatives, designed as cis-restricted combretastatin A-4 analogues, were synthesized and evaluated for their antiproliferative activities. The results indicated that analogue 20 showed more potent antiproliferative activities against PC-3 cell lines than positive control CA-4. Particularly, the most promising compound 25 displayed 5-fold improvement compared to CA-4 in inhibiting HCT116 cell proliferation with IC50 values of 1.15 μM. Further flow-activated cell sorting analysis revealed that compound 20 displayed a significant effect on G2/M cell-cycle arrest in a dose-dependent manner in PC-3 cells. From this study, analogues 20 and 25 were the most potent anti-cancer agents in this structural class, and were considered lead compounds for further development as anti-cancer drugs.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001632 Bibenzyls Compounds that include 1,2-diphenylethane in their structure. Bisbenzyls
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
May 2010, Journal of medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
April 2020, Bioorganic & medicinal chemistry letters,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
October 2015, European journal of medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
August 2016, Bioorganic & medicinal chemistry letters,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
May 2008, Bioorganic & medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
April 2007, Journal of medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
April 2014, Journal of medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
January 2018, European journal of medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
December 2017, European journal of medicinal chemistry,
Yan-Hong Li, and Bei Zhang, and Hai-Kui Yang, and Qiu Li, and Peng-Cheng Diao, and Wen-Wei You, and Pei-Liang Zhao
November 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!